跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 39 条关于
“Mitavipat”
全部
39
临床试验
24
药物
1
机构
0
资讯
14
5个月前
Scientists Win $3 Million Prize for Breakthrough Research Leading to First CRISPR Sickle Cell Therapy
3年前
Mitapivat Shows Durable Improvements in Thalassemia Patients in Phase 2 Extension Study
4年前
FDA Approves Pyrukynd (mitapivat) for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency
去年
Agios' Mitapivat Receives Positive CHMP Opinion for Thalassemia Treatment in Europe
去年
Phase 3 RISE UP Trial of Mitapivat in Sickle Cell Disease Completes Enrollment
去年
Mitapivat Shows Promise in Phase 3 Trial for Transfusion-Dependent Thalassemia
10个月前
Agios' Mitapivat Shows Mixed Results in Phase 3 Sickle Cell Disease Trial
10个月前
Agios' Mitapivat Shows Mixed Results in Sickle Cell Disease Phase 3 Trial
9个月前
FDA Extends Review Timeline for Agios' Mitapivat Thalassemia Application Beyond PDUFA Date
去年
Agios Pharmaceuticals Reports Strong Q3 2024 Driven by Vorasidenib Milestone and Mitapivat Progress
第 1 页,共 2 页
上一页
下一页